Maynard Um
-
-
-
-
-
-
-
J&J Is Said To Explore $20b-plus Sale Of Orthopedics Unit - Bloomberg
-
-
-
-
-
-
-
J&J's AKEEGA gets EU panel backing for prostate cancer expansion
-
-
-
-
-
-
-
Johnson & Johnson (JNJ) PT Raised to $220 at Stifel
-
-
-
-
-
-
-
Johnson & Johnson (JNJ) call put ratio 2.2 calls to 1 put into quarter results
-
-
-
-
-
-
-
Johnson & Johnson (JNJ) call put ratio 2.7 calls more active than puts into the annual J.P. Morgan Healthcare Conference
-
-
-
-
-
-
-
Johnson & Johnson ends atopic dermatitis drug trial early over low efficacy
-
-
-
-
-
-
-
RBC Capital Defends Legend (LEGN) For Second Day in a Row As Stock Continues to Push Lower
-
341,965 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

